Nice article that you found. The link the ABC provided for the DOI of the journal article was broken so I wasn't able to give it a deep dive.
The article does state that biogas is definitely the right way to go due to the very caveat you mentioned about anaerobic/aerobic natural decomposition. However, for all I know you could have some budding scientific children if they can already put together well crafted hypotheses.
I am not savvy with the financials of developing large projects but my common sense tells me DEL will be juggling a lot of leveraged debt without NTA backing it up as security. I wouldn't know if banks loan to gross TA, seems like that'd lead to another GFC or something. The interest on a loan like that will probably be eye watering. If the plants are at all delayed, or if there's cost runover (likely in current macro environment) then negative equity could also elevate risk for financing.
Would anyone know the liabilities on the contracts DEL has signed if they cannot deliver on their commitments? E.g. unable to get finance.
- Forums
- ASX - By Stock
- DEL
- Ann: Ceasing to be a substantial holder
Ann: Ceasing to be a substantial holder, page-25
-
-
- There are more pages in this discussion • 9 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add DEL (ASX) to my watchlist
(20min delay)
|
|||||
Last
19.5¢ |
Change
-0.005(2.50%) |
Mkt cap ! $42.95M |
Open | High | Low | Value | Volume |
20.0¢ | 22.0¢ | 19.0¢ | $338.9K | 1.666M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 18761 | 19.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
20.5¢ | 200000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 18761 | 0.195 |
4 | 188143 | 0.190 |
2 | 86469 | 0.185 |
2 | 10000 | 0.180 |
3 | 336063 | 0.165 |
Price($) | Vol. | No. |
---|---|---|
0.205 | 200000 | 1 |
0.210 | 202751 | 3 |
0.215 | 230444 | 3 |
0.220 | 134810 | 8 |
0.225 | 79302 | 2 |
Last trade - 16.10pm 13/11/2024 (20 minute delay) ? |
Featured News
DEL (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online